| 标题 |
Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy |
| 网址 | |
| DOI |
10.1016/j.jcyt.2021.07.013
doi
|
| 其它 |
Abstract Adenoviruses (Ads), common self-limiting pathogens in humans and animals, usually cause conjunctivitis, mild upper respiratory tract infection or gastroenteritis in humans and hepatotoxicity syndrome in chickens and dogs, posing great threats to public health and livestock husbandry. Artificially modified Ads, which wipe out virulence-determining genes, are the most frequently used viral vectors in gene therapy, and some Ad vector (AdV)-related medicines and vaccines have been licensed and applied. Inherent liver tropism enables AdVs to specifically deliver drugs/genes to the liver; however, AdVs are closely associated with acute hepatotoxicity in immunocompromised individuals, and the side effects of AdVs, which stimulate a strong inflammatory reaction in the liver and cause acute hepatotoxicity, have largely limited clinical application. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)